Symptomatic and hemodynamic benefit of pentaerythrityl tetranitrate and hydralazine in a case of congestive heart failure.

Suppr

超能文献

作者信息

Gori Tommaso, Münzel Thomas

机构信息

2. Medizinische Klinik, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany.

出版信息

Clin Res Cardiol. 2009 Oct;98(10):677-9. doi: 10.1007/s00392-009-0053-x. Epub 2009 Jul 31.

DOI:10.1007/s00392-009-0053-x

PMID:19644645

Abstract

摘要

相似文献

Symptomatic and hemodynamic benefit of pentaerythrityl tetranitrate and hydralazine in a case of congestive heart failure.

Clin Res Cardiol. 2009 Oct;98(10):677-9. doi: 10.1007/s00392-009-0053-x. Epub 2009 Jul 31.

[Peripheral vasodilator in cardiac insufficiency in the acute period of myocardial infarction].[心肌梗死急性期心脏功能不全时的外周血管扩张剂]

Sov Med. 1985(2):54-6.

[Special place of PETN among nitrates. No tolerance development, fewer headaches].[PETN在硝酸盐中的特殊地位。无耐受性产生，头痛较少]

MMW Fortschr Med. 2008 Jan 17;150(1-2):41.

Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.慢性心力衰竭患者使用哪种血管扩张剂？卡托普利和肼屈嗪的随机对照研究。

Br J Clin Pharmacol. 1991 Jan;31(1):25-32. doi: 10.1111/j.1365-2125.1991.tb03853.x.

Effects of hydralazine on pressure-volume and stress-volume relations in congestive heart failure secondary to idiopathic dilated cardiomyopathy.

Am J Cardiol. 1985 Oct 1;56(10):690-5. doi: 10.1016/0002-9149(85)91037-9.

Treatment of pre-existing cardiomyopathy during pregnancy.孕期已有心肌病的治疗。

Acta Cardiol. 2014 Apr;69(2):193-6. doi: 10.1080/ac.69.2.3017302.

Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination.血管扩张剂作为充血性心力衰竭的一线治疗：肼屈嗪、地高辛及其联合用药的血流动力学对比研究

Am Heart J. 1987 Jul;114(1 Pt 1):91-6. doi: 10.1016/0002-8703(87)90312-7.

Pentaerythritol Tetranitrate Targeting Myocardial Reactive Oxygen Species Production Improves Left Ventricular Remodeling and Function in Rats With Ischemic Heart Failure.靶向心肌活性氧生成的季戊四醇四硝酸酯可改善缺血性心力衰竭大鼠的左心室重构和功能

Hypertension. 2015 Nov;66(5):978-87. doi: 10.1161/HYPERTENSIONAHA.115.05931. Epub 2015 Sep 8.

[Long-term vasodilator therapy of chronic refractory heart failure in patients with dilated cardiomyopathy].[扩张型心肌病患者慢性难治性心力衰竭的长期血管扩张剂治疗]

J Cardiogr Suppl. 1986(9):77-85.

Sustained benefits or oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure.口服季戊四醇四硝酸酯对慢性充血性心力衰竭患者心室功能的持续益处。

Clin Pharmacol Ther. 1980 Oct;28(4):436-40. doi: 10.1038/clpt.1980.185.

引用本文的文献

Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates.不同有机硝酸酯类药物治疗期间对缺血再灌注诱导的内皮功能障碍的慢性保护作用。

Clin Res Cardiol. 2012 Jun;101(6):453-9. doi: 10.1007/s00392-012-0412-x.

本文引用的文献

Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure.硝酸异山梨酯和肼屈嗪作为晚期失代偿性心力衰竭出院患者的附加治疗的有效性。

Am J Cardiol. 2009 Apr 15;103(8):1113-9. doi: 10.1016/j.amjcard.2008.12.028. Epub 2009 Feb 21.

Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate.有机硝酸盐的非血流动力学效应及戊四硝酯的独特特性。

Am J Cardiovasc Drugs. 2009;9(1):7-15. doi: 10.1007/BF03256591.

Nitrate-induced toxicity and preconditioning: a rationale for reconsidering the use of these drugs.硝酸盐诱导的毒性与预处理：重新审视这些药物使用的理论依据。

J Am Coll Cardiol. 2008 Jul 22;52(4):251-4. doi: 10.1016/j.jacc.2008.04.019.

New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance.有机硝酸盐生物活化、硝酸盐耐受性和交叉耐受性的新见解。

Clin Res Cardiol. 2008 Jan;97(1):12-20. doi: 10.1007/s00392-007-0588-7. Epub 2007 Oct 19.

Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.硝酸异山梨酯和肼屈嗪固定剂量联合用药可使接受规范治疗的黑人心力衰竭患者的左心室重构进一步消退：A-HeFT研究结果

J Card Fail. 2007 Jun;13(5):331-9. doi: 10.1016/j.cardfail.2007.03.001.

Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure.肼屈嗪是一种强力的过氧亚硝酸盐形成抑制剂，这可能是其对充血性心力衰竭患者预后产生有益影响的一个解释。

Biochem Biophys Res Commun. 2005 Dec 30;338(4):1865-74. doi: 10.1016/j.bbrc.2005.10.106. Epub 2005 Nov 11.

Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.硝酸盐和肼苯哒嗪在心力衰竭中的作用：非裔美国人心力衰竭试验之前的临床证据。

Am J Cardiol. 2005 Oct 10;96(7B):37i-43i. doi: 10.1016/j.amjcard.2005.07.031. Epub 2005 Aug 9.

Survey of the use of organic nitrates for the treatment of chronic congestive heart failure in the United States.

Am J Cardiol. 2004 Dec 1;94(11):1465-8. doi: 10.1016/j.amjcard.2004.07.155.

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.硝酸异山梨酯与肼苯哒嗪联合用于黑人心力衰竭患者

N Engl J Med. 2004 Nov 11;351(20):2049-57. doi: 10.1056/NEJMoa042934. Epub 2004 Nov 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验